These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6036394)
1. Dissociation between thyroid injury and formation of long-acting thyroid stimulator in thyrotoxicosis. Burke G Ann Intern Med; 1967 Aug; 67(2):349-55. PubMed ID: 6036394 [No Abstract] [Full Text] [Related]
3. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis. Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447 [No Abstract] [Full Text] [Related]
4. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis. Alford FP; Larkins RG; Martin FI Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990 [No Abstract] [Full Text] [Related]
5. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy. Burke G; Silverstein GE JAMA; 1969 Nov; 210(6):1051-8. PubMed ID: 4900342 [No Abstract] [Full Text] [Related]
6. A COMPARISON OF THE HEAT STABILITY OF LONG-ACTING THYROID STIMULATOR AND HUMAN THYROID-STIMULATING HORMONE. MCGIVEN AR; ADAMS DD; PURVES HD J Endocrinol; 1965 Apr; 32():29-33. PubMed ID: 14275678 [No Abstract] [Full Text] [Related]
7. Evaluation of the relationship between long-acting thyroid stimulator, clinical and biological thyrotoxicosis and exophthalmos. Bonnyns M; Demeester-Mirkine N; Calay R; Bastenie PA Acta Endocrinol (Copenh); 1968 Aug; 58(4):581-92. PubMed ID: 5695780 [No Abstract] [Full Text] [Related]
8. Studies on the pathogenesis of the ophthalmopathy of Graves' disease. Kriss JP; Pleshakov V; Rosenblum AL; Holderness M; Sharp G; Utiger R J Clin Endocrinol Metab; 1967 Apr; 27(4):582-93. PubMed ID: 6071430 [No Abstract] [Full Text] [Related]
9. EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR. ADAMS DD; KENNEDY TH J Clin Endocrinol Metab; 1965 May; 25():571-6. PubMed ID: 14313750 [No Abstract] [Full Text] [Related]
15. Studies on the treatment of hyperthyroidism with Iodine-131. Torizuka K; Mori T; Konishi J; Morita R; Hamamoto K; Kusakabe T; Miyake T; Fukase M J Nucl Med; 1967 May; 8(5):335. PubMed ID: 6032620 [No Abstract] [Full Text] [Related]
16. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine]. Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759 [No Abstract] [Full Text] [Related]
17. Serum thyroglobulin levels in healthy subjects and in patients with thyroid disease. Torrigiani G; Doniach D; Roitt IM J Clin Endocrinol Metab; 1969 Mar; 29(3):305-14. PubMed ID: 5773064 [No Abstract] [Full Text] [Related]
18. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator. Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552 [No Abstract] [Full Text] [Related]
19. Induction of a LATS-like response by thyroglobulin in the McKenzie assay system. Wood LC; Burger A; Peterson M; Ingbar SH Endocrinology; 1973 May; 92(5):1538-43. PubMed ID: 4695433 [No Abstract] [Full Text] [Related]
20. A STANDARD FOR THE LONG-ACTING THYROID STIMULATOR (LATS) IN THE SERUM OF PATIENTS WITH THYROTOXICOSIS. DORRINGTON KJ; MUNRO DS J Endocrinol; 1964 Nov; 31():21-8. PubMed ID: 14231127 [No Abstract] [Full Text] [Related] [Next] [New Search]